Japanese Healthtech Stock News

TSE:3154
TSE:3154Healthcare

Medius Holdings Q2 2026 Thin 0.5% Margin Tests Bullish Low P E Narrative

Medius Holdings (TSE:3154) has just posted Q2 2026 results with revenue of ¥77,042.6 million and basic EPS of ¥12.51, while trailing twelve month figures sit at ¥295,196 million of revenue and basic EPS of ¥60.98. Over recent quarters, revenue has moved from ¥73,547 million in Q2 2025 to ¥77,042.6 million in Q2 2026, with EPS shifting from ¥14.93 to ¥12.51 across the same periods. This combination gives investors a mix of steady top line scale and uneven per share earnings, which keeps...
TSE:9619
TSE:9619Transportation

Ichinen Holdings (TSE:9619) Margin Compression Challenges Bullish Value Narrative In Q3 2026 Results

Ichinen HoldingsLtd (TSE:9619) has released its Q3 2026 results, reporting revenue of ¥40.6b and basic EPS of ¥74.54, while net income excluding extra items came in at ¥1.8b for the quarter. The company’s revenue moved from ¥38.6b and EPS of ¥74.27 in Q3 2025 to ¥40.6b and EPS of ¥74.54 in Q3 2026, compared with trailing twelve month revenue of ¥160.0b and EPS of ¥303.48 that provide a broader context. For investors, a key consideration is how comfortably these earnings support margins and...
TSE:6853
TSE:6853Electronic

Kyowa Electronic Instruments (TSE:6853) Margin Improvement Supports Bullish Earnings Narrative

Kyowa Electronic Instruments (TSE:6853) has released its FY 2025 numbers with fourth quarter revenue of ¥4,650 million and basic EPS of ¥13.97, capping a year where trailing twelve month revenue came in at ¥16.27 billion and EPS reached ¥39.27. The company has seen quarterly revenue range between ¥3,550 million and ¥4,650 million over the past year, while quarterly EPS moved from ¥2.86 to ¥17.53, giving investors a clear view of how earnings power has shifted across FY 2025. With net profit...
TSE:2461
TSE:2461Media

FAN Communications (TSE:2461) EPS Slide Reinforces Bearish Earnings Narratives

FAN Communications (TSE:2461) has reported its FY 2025 numbers with fourth quarter revenue of ¥1,674.5 million and basic EPS of ¥4.49, alongside trailing 12 month revenue of ¥7.1 billion and EPS of ¥19.73 that sit against a backdrop of earnings and revenue forecasts pointing to declines over the next three years. The company has seen quarterly revenue move from ¥1,798 million in Q4 FY 2024 to ¥1,674.5 million in Q4 FY 2025, while basic EPS shifted from ¥6.40 to ¥4.49 over the same period...
TSE:1870
TSE:1870Construction

Yahagi Construction (TSE:1870) Q3 EPS Slowdown Tests Bullish Margin Improvement Narrative

Yahagi ConstructionLtd (TSE:1870) has released its Q3 2026 results, reporting revenue of ¥43.4b and net income of ¥1.6b, which translates to basic EPS of ¥36.74. The company’s revenue increased from ¥38.3b in Q3 2025 to ¥43.4b in Q3 2026, while basic EPS moved from ¥31.40 to ¥36.74 over the same period, providing a clearer view of how both the top line and per share earnings are tracking. With trailing net profit margin reported at 6.1% and earnings growth in recent years contributing to that...
TSE:2374
TSE:2374Healthcare

Saint-Care Holding (TSE:2374) Margin Improvement Challenges Forecast Earnings Decline Narrative

Saint-Care Holding (TSE:2374) has posted Q3 2026 revenue of ¥14.7b and basic EPS of ¥17.76, with trailing twelve month EPS at ¥68.61 as the company rounds out another quarter of steady top line and earnings delivery. Over recent periods, revenue has moved from ¥14.3b in Q1 2026 to ¥14.6b in Q2 and ¥14.7b in Q3, while quarterly basic EPS has shifted from ¥25.12 in Q1 to ¥17.97 in Q2 and ¥17.76 in Q3. With net income running at ¥438m for the quarter and margins that have recently ticked higher,...
TSE:4544
TSE:4544Healthcare

H.U. Group Holdings Q3 Profit Spike And One Off Gain Test Bullish Recovery Narratives

H.U. Group Holdings (TSE:4544) has just posted Q3 2026 numbers with revenue of ¥62,337 million and basic EPS of ¥97.32, while trailing twelve month revenue stands at ¥247,707 million and basic EPS at ¥98.63. Over recent quarters, the company has seen quarterly revenue move between ¥60,520 million and ¥62,997 million, with basic EPS ranging from a loss of ¥21.07 to a profit of ¥97.32. This gives investors a clear view of how earnings have swung against a relatively steady top line. With a...
TSE:3932
TSE:3932Entertainment

Akatsuki (TSE:3932) Net Margin At 15.7% Tests Bearish Earnings Volatility Narrative

Akatsuki (TSE:3932) has reported Q3 2026 revenue of ¥6.6b and basic EPS of ¥69.55, with trailing twelve month EPS at ¥261.09 set against revenue of ¥24.0b and net income of ¥3.8b. The company has seen quarterly revenue move from ¥7.5b in Q4 2025 to ¥7.6b in Q2 2026, before this quarter’s ¥6.6b print, while basic EPS shifted from ¥63.04 in Q4 2025 to ¥209.43 in Q2 2026 and ¥69.55 in Q3 2026. This pattern sits alongside an annualized 178.7% earnings uplift over the longer term trend and a...
TSE:5195
TSE:5195Machinery

Bando Chemical Industries (TSE:5195) Q3 Profit Recovery Tests Bullish Earnings Narratives

Bando Chemical Industries (TSE:5195) has released its Q3 2026 results, reporting revenue of ¥30.1b and basic EPS of ¥57.13, while trailing 12 month figures show revenue of ¥117.5b and EPS of ¥106.31. Over recent quarters the company has seen revenue move from ¥28.3b in Q4 2025 to ¥29.1b in Q1 2026 and ¥30.0b in Q2 2026. Basic EPS shifted from a loss of ¥65.52 in Q4 2025 to profits of ¥63.53 in Q1 2026 and ¥52.38 in Q2 2026. Q3’s results therefore provide another reference point for how...
TSE:6089
TSE:6089Professional Services

Will Group (TSE:6089) Q3 EPS Strength Tests Bearish Earnings Narrative

Will Group (TSE:6089) has posted its Q3 2026 numbers with revenue of ¥37,097 million and net income of ¥832 million, translating to basic EPS of ¥36.31. The company has seen revenue move from ¥35,030 million in Q3 2025 to ¥37,097 million in Q3 2026, while quarterly EPS shifted from ¥26.73 to ¥36.31 over the same period, reshaping how its earnings trend looks heading into the final stretch of the fiscal year. With a trailing net profit margin sitting at 1.3%, the latest results put the...
TSE:6137
TSE:6137Machinery

Koike Sanso Kogyo (TSE:6137) EPS Rebound Vs Bearish Margin Narrative In Q3 2026

Koike Sanso KogyoLtd (TSE:6137) has put up a busy Q3 2026 scorecard, with revenue at about ¥13.9b and basic EPS of ¥60.21, underpinned by net income of ¥1,271m for the quarter. The company has seen quarterly revenue move from ¥13.7b in Q2 2025 to ¥13.9b in Q3 2026, while basic EPS has ranged from ¥37.69 in Q2 2025 to ¥60.21 in the latest quarter. This sets the scene for investors to focus closely on how margins are holding up through this reporting run. See our full analysis for Koike Sanso...
TSE:4966
TSE:4966Chemicals

C.Uyemura (TSE:4966) Net Margin Near 17% Tests Bullish Quality Narrative After Q3 Results

C.Uyemura Ltd (TSE:4966) just posted Q3 2026 revenue of ¥24.3b and basic EPS of ¥278.48, with the trailing twelve months showing revenue of ¥86.5b and EPS of ¥899.34 as the longer term backdrop. The company has seen revenue move from ¥22.6b and EPS of ¥260.25 in Q3 2025 to the latest Q3 2026 figures. This feeds into a trailing net margin profile that keeps the focus squarely on how efficiently those sales are turning into profit. See our full analysis for C.UyemuraLtd. With the headline...
TSE:4613
TSE:4613Chemicals

Kansai Paint (TSE:4613) Margin Compression In Q3 2026 Tests Steady Compounder Narrative

Kansai Paint (TSE:4613) has put Q3 2026 numbers on the table with revenue of ¥153.2b and basic EPS of ¥78.35, giving investors a fresh read on how the year is shaping up. The company has seen revenue move from ¥150.7b and basic EPS of ¥94.82 in Q3 2025 to ¥153.2b and ¥78.35 in Q3 2026. Trailing twelve month EPS sits at ¥200.28 and total revenue at ¥586.5b, setting the scene for how you judge the latest margin picture. See our full analysis for Kansai Paint. With the headline numbers out, the...
TSE:7287
TSE:7287Auto Components

Assessing Nippon Seiki (TSE:7287) Valuation After Strong Nine‑Month Earnings And Profitability Improvement

Nippon Seiki (TSE:7287) has come into focus after reporting earnings for the nine months to December 31, 2025, with sales of ¥234,362 million and net income of ¥6,608 million. See our latest analysis for Nippon Seiki. The earnings release, together with the recent decision to dissolve the capital and business alliance with Alps Alpine and move to a pure business alliance, has coincided with a sharp pickup in momentum. The 30 day share price return of 17.36% and the 1 year total shareholder...
TSE:9107
TSE:9107Shipping

A Look At Kawasaki Kisen Kaisha (TSE:9107) Valuation After Dividend Hike Guidance Revision And New CCS Charter

Guidance revision, dividend plans, and new CCS charter reshape the story Kawasaki Kisen Kaisha (TSE:9107) has updated earnings guidance, outlined higher dividend plans for the 2027 fiscal year, and secured a long term liquefied CO2 carrier charter that ties the business to carbon capture and storage projects. See our latest analysis for Kawasaki Kisen Kaisha. These guidance changes, dividend plans and the new CCS charter come against a backdrop of building momentum, with a 10.76% 90 day share...
TSE:7181
TSE:7181Insurance

Is Japan Post Insurance's (TSE:7181) Stock Split Quietly Reframing Its Long-Term Investor Story?

Japan Post Insurance Co., Ltd. disclosed that its Board of Directors on January 29, 2026 resolved to conduct a stock split and make associated partial amendments to its Articles of Incorporation, formalizing the changes through a board meeting agenda focused on these items. This combination of a stock split and governance-related amendments represents a meaningful adjustment to the company’s capital structure and corporate framework, which can influence how investors assess its accessibility...
TSE:4902
TSE:4902Tech

Konica Minolta (TSE:4902) Valuation Check After Profit Rebound And Market Reaction To Latest Earnings

Konica Minolta (TSE:4902) has drawn fresh attention after reporting nine-month earnings to December 31, 2025, with net income of ¥21,436 million compared to a net loss of ¥13,399 million a year earlier. See our latest analysis for Konica Minolta. The earnings announcement appears to have given the share price a short term lift, with a 1 day share price return of 3.38% to ¥624.0. However, the 30 day share price return of 10.95% and year to date share price return of 9.64% are weaker, while the...
TSE:8381
TSE:8381Banks

Assessing San-in Godo Bank (TSE:8381) Valuation After Strong Earnings And Higher Year-End Dividend

San-in Godo Bank Ltd (TSE:8381) is back on investor radars after reporting higher net income and earnings per share for the nine months to December 31, 2025, alongside an increased year-end dividend. See our latest analysis for San-in Godo BankLtd. The earnings beat, higher year end dividend of ¥28.00 per share, and completion of the ¥999.88m share buyback appear to have gone hand in hand with stronger momentum, with a 90 day share price return of 26.63% and a 1 year total shareholder return...
TSE:4665
TSE:4665Commercial Services

A Look At Duskin (TSE:4665) Valuation After China Mister Donut Reentry And Higher Nine Month Earnings

Duskin (TSE:4665) has been back in focus after it agreed a master franchise deal to reintroduce the Mister Donut brand to East China, alongside reporting nine month earnings that showed higher sales and net income year on year. See our latest analysis for Duskin. The Mister Donut re entry into East China and the latest nine month earnings update appear to have contributed to growing momentum, with Duskin’s 90 day share price return of 11.76% alongside a 1 year total shareholder return of...
TSE:4502
TSE:4502Pharmaceuticals

Is It Too Late To Consider Takeda Pharmaceutical (TSE:4502) After Its Strong 1-Year Rally?

If you are wondering whether Takeda Pharmaceutical's share price still offers value after its recent performance, this article will walk through what the current market price might be implying. The stock last closed at ¥5,565, with returns of 2.7% over 7 days, 9.5% over 30 days, 13.2% year to date, 41.7% over 1 year and 50.5% over 3 years. These figures may catch the eye of investors thinking about growth potential or shifts in risk perception. Recent news flow around Takeda Pharmaceutical...
TSE:8473
TSE:8473Capital Markets

How Investors May Respond To SBI Holdings (TSE:8473) Earnings Strength And Strium Onchain Securities Launch

In early February 2026, Startale Group and SBI Holdings launched Strium, a blockchain-based exchange infrastructure designed for 24/7 trading and settlement of tokenized equities and real-world asset-linked instruments across spot and derivatives markets in Asia, while keeping issuance and custody separate for compatibility with existing financial systems. A day earlier, SBI Holdings reported that for the nine months ended December 31, 2025, sales rose to ¥1.49 trillions and net income to...
TSE:8801
TSE:8801Real Estate

Mitsui Fudosan (TSE:8801) Valuation Check After Upgraded Earnings Guidance And Strong Nine Month Results

Why Mitsui Fudosan’s latest earnings matter for shareholders Mitsui Fudosan (TSE:8801) just reported nine month results to December 31, 2025, alongside an upward revision to full year earnings forecasts, putting fresh attention on how the real estate group’s fundamentals stack up. See our latest analysis for Mitsui Fudosan. The earnings beat and upgraded guidance on 6 February sit alongside a sharp pick up in momentum, with a 7 day share price return of 17.11% and a 1 year total shareholder...
TSE:3436
TSE:3436Semiconductor

Is Sumco (TSE:3436) Using Leadership Shifts To Reframe Its Long-Term Governance Story?

Sumco Corporation recently held its 2025 earnings call and a board meeting on February 10, 2026, to review performance and decide on personnel changes. The combination of financial disclosure and potential leadership adjustments offers fresh insight into how Sumco may be positioning its operations and governance. We will now examine how the earnings call and its focus on personnel changes could influence Sumco's broader investment narrative. Invest in the nuclear renaissance through our list...
TSE:4063
TSE:4063Chemicals

Does Shin-Etsu Chemical's (TSE:4063) Equity Raise Amid Softer Earnings Reframe Its Capital Allocation Play?

In January 2026, Shin-Etsu Chemical Co., Ltd. reported nine-month results to December 31, 2025, with sales of ¥1.93 trillion and lower net income of ¥384.32 billion year-on-year. On the same day, the board approved a secondary share offering, highlighting management’s decision to tap equity markets while earnings momentum softened. We’ll now examine how the earnings softness alongside the newly approved secondary share offering may influence Shin-Etsu Chemical’s investment narrative. Find 22...